1. Home
  2. CRT vs ASRT Comparison

CRT vs ASRT Comparison

Compare CRT & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRT
  • ASRT
  • Stock Information
  • Founded
  • CRT 1991
  • ASRT 1995
  • Country
  • CRT United States
  • ASRT United States
  • Employees
  • CRT N/A
  • ASRT N/A
  • Industry
  • CRT Oil & Gas Production
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRT Energy
  • ASRT Health Care
  • Exchange
  • CRT Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • CRT 65.1M
  • ASRT 57.9M
  • IPO Year
  • CRT 1992
  • ASRT 1997
  • Fundamental
  • Price
  • CRT $10.03
  • ASRT $0.61
  • Analyst Decision
  • CRT
  • ASRT Strong Buy
  • Analyst Count
  • CRT 0
  • ASRT 3
  • Target Price
  • CRT N/A
  • ASRT $3.08
  • AVG Volume (30 Days)
  • CRT 23.9K
  • ASRT 305.8K
  • Earning Date
  • CRT 01-01-0001
  • ASRT 05-12-2025
  • Dividend Yield
  • CRT 8.79%
  • ASRT N/A
  • EPS Growth
  • CRT N/A
  • ASRT N/A
  • EPS
  • CRT 0.95
  • ASRT N/A
  • Revenue
  • CRT $6,623,430.00
  • ASRT $124,961,000.00
  • Revenue This Year
  • CRT N/A
  • ASRT N/A
  • Revenue Next Year
  • CRT N/A
  • ASRT $11.20
  • P/E Ratio
  • CRT $10.66
  • ASRT N/A
  • Revenue Growth
  • CRT N/A
  • ASRT N/A
  • 52 Week Low
  • CRT $8.88
  • ASRT $0.51
  • 52 Week High
  • CRT $14.40
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • CRT 42.20
  • ASRT 43.47
  • Support Level
  • CRT $9.91
  • ASRT $0.58
  • Resistance Level
  • CRT $10.46
  • ASRT $0.66
  • Average True Range (ATR)
  • CRT 0.38
  • ASRT 0.05
  • MACD
  • CRT -0.00
  • ASRT 0.00
  • Stochastic Oscillator
  • CRT 14.85
  • ASRT 23.53

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: